Individualized 6 ‐mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: a NOPHO randomized controlled trial

ConclusionThis study found no benefit from individualized 6‐mercaptopurine increments compared to standard therapy.This article is protected by copyright. All rights reserved.

Source: European Journal of Haematology - October 6, 2017 Category: Hematology Authors: Morten Tulstrup, Thomas L. Frandsen, Jonas Abrahamsson, Bendik Lund, Kim Vettenranta, Olafur Gisli Jonsson, Hanne Vibeke Hansen Marquart, Birgitte Klug Albertsen, Mats Heyman, Kjeld Schmiegelow, Tags: Original Article Source Type: research